Target intelligence / Profile preview

Human cytomegalovirus immediate early protein 1 (IE1)

Target
IE1
Molecular classification
Other (viral regulatory protein)
01

Overview

Human cytomegalovirus immediate early protein 1 (IE1) is a 491 amino acid, nuclear regulatory phosphoprotein that is abundantly expressed at the onset of infection. IE1 is a multifunctional protein critical for initiating lytic infection, reactivating from latency, and modulating host cell environment to favor viral replication. It acts as a promiscuous transcriptional regulator, modifying chromatin to activate viral and host genes, dampening host immune responses through disruption of PML nuclear bodies and by manipulating STAT signaling pathways. The protein contains distinct regions including a chromatin tethering domain (CTD) required for mitotic chromosome association, mapped to exon 4, which is critical for chromatin attachment and immune evasion. IE1’s structure is unique among viral proteins and has evolved specifically to neutralize cellular defense mechanisms, particularly PML nuclear bodies and associated factors.

Other names
IE1IE1-72kDaImmediate-early protein 1UL123
02

Mechanism of action

NA; no approved drugs directly target IE1

03

Biological functions

Transcriptional activation of viral and cellular genesChromatin modificationAntagonism of intrinsic and innate immunity (e.g. PML nuclear body disruption)Interaction with host signal transduction (e.g. STAT pathway modulation)
04

Disease associations

Infection (specifically, cytomegalovirus/HCMV infection)Immune evasionViral latency and reactivation
05

Safety considerations

No drugs directly targeting IE1 are in clinical use, but theoretical concerns would include interference with host immune signaling and chromatin regulation
06

Interacting drugs

None currently approved
07

Biomarkers

Expression of IE1 is used as a marker of active HCMV infection or viral reactivation

Beyond the preview

Go deeper on Human cytomegalovirus immediate early protein 1 (IE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human cytomegalovirus immediate early protein 1 (IE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call